Retraction: Bak compensated for bax in p53-null cells to release cytochrome c for the initiation of mitochondrial signaling during withanolide d-induced apoptosis (PLoS ONE (2012) 7:3 (e34277) DOI: 10.1371/journal.pone.0034277);Bak compensated for bax in p53-null cells to release cytochrome c for the initiation of mitochondrial signaling during withanolide D-induced apoptosis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Mondal, Susmita ^a,c   Bhattacharya, Kaushik ^a   Mallick, Asish ^a   Sangwan, Rajender ^b   Mandal, Chitra ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

^c Sammilani Mahavidyalaya ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C; PIFITHRIN ALPHA; PROTEIN BAK; PROTEIN BAX; PROTEIN P53; UNCLASSIFIED DRUG; WITHANOLIDE; WITHANOLIDE D; ANTINEOPLASTIC AGENT; BAK1 PROTEIN, HUMAN; BAK1 PROTEIN, MOUSE; BAX PROTEIN, HUMAN; BAX PROTEIN, MOUSE; TP53 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; OLIGOMERIZATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SURVIVAL TIME; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; CANCER TRANSPLANTATION; CELL STRAIN K 562; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUDE MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

WITHANIA SOMNIFERA;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CYTOCHROMES C; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; K562 CELLS; MICE; MICE, NUDE; MITOCHONDRIA; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; WITHANOLIDES;

EID: 84859092553     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0228839     Document Type: Erratum

References (39)

1. Kasibhatla S, Tseng B, (2003) Why Target Apoptosis in Cancer Treatment? Mol Cancer Ther 2: 573-580.
2. Gogvadze V, Orrenius S, Zhivotovsky B, (2009) Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol 19: 57-66.
3. Vaseva AV, Moll UM, (2009) The mitochondrial p53 pathway. Biochim Biophys Acta 1787: 414-20.
4. Oren M, (2003) Decision making by p53: life, death and cancer. Cell Death Differ 10: 431-442.
5. Vousden KH, Prives C, (2009) Blinded by the light: the growing complexity of p53. Cell 137: 413-431.
6. Miyashita T, Harigai M, Hanada M, Reed JC, (1994) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131-3135.
7. Sugars KL, Budhram-Mahadeo V, Packham G, Latchman DS, (2001) A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53. Nucleic Acids Res 29: 4530-4540.
8. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M, (2002) Transcriptional repression of the anti apoptotic survivin gene by wild type p53. J Biol Chem 277: 3247-3257.
9. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B, (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290: 989-992.
10. Pietsch EC, Perchiniak E, Canutescu AA, Wang G, Dunbrack RL, et al. (2008) Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain. J Biol Chem 283: 21294-21304.
11. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, et al. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058.
12. Billen LP, Shamas-Din A, Andrews DW, (2008) Bid: a Bax-like BH3 protein. Oncogene 27 (Suppl 1): S93-104.
13. Madesh M, Antonsson B, Srinivasula SM, Alnemri ES, Hajnóczky G, (2002) Rapid kinetics of tBid-induced cytochrome c and Smac/DIABLO release and mitochondrial depolarization. J Biol Chem 277: 5651-9.
14. Mondal S, Bandyopadhyay S, Ghosh MK, Mukhopadhyay S, Roy S, et al. (2012) Natural Products: Promising Resources For Cancer Drug Discovery. Anticancer Agents Med Chem 12: 49-75.
15. Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B, (1996) Studies on the immunomodulatory effects of Ashwagandha. J Ethnopharmacol 50: 69-76.
16. Agarwal R, Diwanay S, Patki P, Patwardhan B, (1999) Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation. J Ethnopharmacol 67: 27-35.
17. Rasool M, Varalakshmi P, (2007) Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats. Fundam Clin Pharmacol 21: 157-164.
18. Jayaprakasam B, Zhang Y, Seeram NP, Nair MG, (2003) Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci 74: 125-132.
19. Iuvone T, Esposito G, Capasso F, Izzo AA, (2003) Induction of nitric oxide synthase expression by Withania somnifera in macrophages. Life Sci 72: 1617-1625.
20. Mondal S, Mandal C, Sangwan R, Chandra S, Mandal C, (2010) Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. Mol Can 9: 239.
21. Tokino T, Nakamura Y, (2000) The role of p53-target genes in human cancer. Crit Rev Oncol Hematol 33: 1-6.
22. Kluck RM, Wetzel EB, Green DR, Newmeyer DD, (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-6.
23. Madesh M, Zong WX, Hawkins BJ, Ramasamy S, Venkatachalam T, et al. (2009) Execution of superoxide-induced cell death by the proapoptotic Bcl-2-related proteins Bid and Bak. Mol Cell Biol 29: 3099-112.
24. Vogelstein B, Lane D, Levine AJ, (2000) Surfing the p53 network. Nature 408: 307-310.
25. Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, et al. (1998) p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 188: 2033-2045.
26. Wu GS, Burns TF, McDonald ER 3rd, Jiang W, Meng R, et al. (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17: 141-143.
27. Leu JI, Dumont P, Hafey M, Murphy ME, George DL, (2004) Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6: 443-50.
28. Li H, Zhu H, Xu CJ, Yuan J, (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501.
29. Haupt S, Berger M, Goldberg Z, Haupt Y, (2003) Apoptosis - the p53 network. J Cell Sci 116: 4077-85.
30. Nagata S, Golstein P, (1995) The Fas death factor. Science 267: 1449-1456.
31. O'Connor L, Harris AW, Strasser A, (2000) CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types. Cancer Res 60: 1217-1220.
32. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, et al. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-30.
33. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, et al. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010-4.
34. Degenhardt K, Chen G, Lindsten T, White E, (2002) BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell 2: 193-203.
35. Chaurasiya ND, Uniyal GC, Lal P, Misra L, Sangwan NS, et al. (2008) Analysis of withanolides in root and leaf of Withania somnifera by HPLC with photodiode array and evaporative light scattering detection. Phytochem Anal 19: 148-54.
36. Bhattacharya K, Samanta SK, Tripathi R, Mallick A, Chandra S, et al. (2010) Apoptotic effects of mahanine on human leukemic cells are mediated through crosstalk between Apo-1/Fas signaling and the Bid protein and via mitochondrial pathways. Biochem Pharmacol 79: 361-72.
37. Dewson G, Kratina T, Sim HW, Puthalakath H, Adams JM, et al. (2008) To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. Mol Cell 30: 369-80.
38. Mandal C, Tringali C, Mondal S, Anastasia L, Chandra S, et al. (2010) Down regulation of membrane-bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells. Int J Cancer 126: 337-49.
39. Mandal C, Dutta A, Mallick A, Chandra S, Misra L, et al. (2008) Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis 13: 1450-64.